COMMUNIQUÉS West-GlobeNewswire

Aclaris Therapeutics Announces ATI-450 (MK2 pathway Inhibitor) publication in the Journal Cancer Research

21/08/2018 - 13:00

WAYNE, Pa., Aug. 21, 2018 (GLOBE NEWSWIRE) -- Aclaris Therapeutics, Inc. (NASDAQ:ACRS), a dermatologist-led biopharmaceutical company focused on identifying, developing, and commercializing innovative therapies to [...]

Tonix Pharmaceuticals Presents Results and Retrospective Analyses of Two Double-Blind, Randomized Placebo-Controlled 12-Week Studies of Tonmya® in Military-Related PTSD at the 2018 Military Health System Research Symposium

21/08/2018 - 13:00

Retrospective Analysis of the Discontinued Phase 3 P301 “HONOR” Study Revealed Clinically Meaningful Response to Tonmya in PTSD Participants with Trauma Experienced Within Nine Years Prior to Screening but Not in [...]

Auxly Announces Acquisition of Leading Canadian Contract Research Organization KGK Science

21/08/2018 - 13:00

VANCOUVER, British Columbia, Aug. 21, 2018 (GLOBE NEWSWIRE) -- Auxly Cannabis Group Inc. (TSX.V - XLY) (" Auxly " or the " Company ") is pleased to announce that it has entered into a share purchase agreement (the “ [...]

Capricor Therapeutics Presents Results of Studies of CAP-2003 at Gordon Research Conference on Extracellular Vesicles

21/08/2018 - 13:00

Research Demonstrates the Investigational Therapy’s Mechanism of Action and Immunomodulatory Capacities LOS ANGELES, Aug. 21, 2018 (GLOBE NEWSWIRE) -- At the Gordon Research Conference on Extracellular Vesicles in Newry [...]

PetVivo Holdings, Inc. Adds Three New Board Members

21/08/2018 - 13:00

MINNEAPOLIS, Aug. 21, 2018 (GLOBE NEWSWIRE) -- (OTCMARKET:PETV), PetVivo Holdings, Inc. ( www.petvivo.com ), an emerging biomedical device company, is pleased to announce the addition of Ms. Sherry Grisewood CFA, Mr. [...]

International Stem Cell Corporation Granted Key US Patent Protecting Lead Therapeutic Program

21/08/2018 - 13:00

CARLSBAD, Calif., Aug. 21, 2018 (GLOBE NEWSWIRE) -- International Stem Cell Corporation (OTCQB: ISCO) ( www.internationalstemcell.com ) ("ISCO" or "the Company"), a California-based clinical stage biotechnology company [...]

Aptinyx Presents Preclinical Data from Fast-Track Designated PTSD Program at Military Health System Research Symposium

21/08/2018 - 12:35

EVANSTON, Ill., Aug. 21, 2018 (GLOBE NEWSWIRE) -- Aptinyx Inc. (NASDAQ:APTX), a clinical-stage biopharmaceutical company developing transformative therapies for the treatment of brain and nervous system disorders, today [...]

Emblem enters into a supply agreement with operator of the Ontario Cannabis Store for high quality, Ontario-grown cannabis

21/08/2018 - 12:30

Emblem selected as one of 26 licensed producers to supply Ontario for adult-use market PARIS, Ontario, Aug. 21, 2018 (GLOBE NEWSWIRE) -- Emblem Corp. (TSXV:EMC) (TSXV:EMC.WT) (“Emblem” or the "Company") is pleased to [...]

Achillion Appoints Dr. Steven Zelenkofske as Chief Medical Officer and Further Strengthens Clinical Development Team

21/08/2018 - 12:00

NEW HAVEN, Conn., Aug. 21, 2018 (GLOBE NEWSWIRE) -- Achillion Pharmaceuticals, Inc. (NASDAQ: ACHN) today announced the appointment of Steven Zelenkofske, D.O. to the position of Executive Vice President and Chief [...]

Genetic Technologies Limited Invited by Representatives of the Hainan Government to Discuss Market Entry into China

21/08/2018 - 11:30

MELBOURNE, Australia, Aug. 21, 2018 (GLOBE NEWSWIRE) -- Representatives of the Hainan Government - Hainan Ecological Smart City Group (“ HESCG ”), a Chinese industrial park development & operations company have [...]

Transactions in relation to share buyback program

21/08/2018 - 10:54

Acting under its share buyback authorization, the GN Store Nord Board of Directors initiated a share buyback program on May 2, 2018, in accordance with article 5 of the regulation (EU) no. 596/2014 of 16 April 2014 on [...]

Immutep Receives A$1.9 Million Research and Development Related Tax Rebate from French Government

21/08/2018 - 10:44

SYDNEY, Australia, Aug. 21, 2018 (GLOBE NEWSWIRE) -- Immutep Limited (ASX: IMM; NASDAQ: IMMP) (“Immutep” or “the Company”), a biotechnology company developing novel immunotherapy treatments for cancer and autoimmune [...]

Correction of geographical distribution in C-RAD ABs Interim report January-June 2018

21/08/2018 - 09:45

Correction of geographical distribution in C-RAD ABs Interim report January-June 2018 In C-RADs Interim Report for January – June, 2018 it has been identified that the figures in a graph of the geographical distribution [...]

Solon Eiendom ASA – Primary insider notification

21/08/2018 - 08:34

(Oslo, Norway, August 20, 2018) UFI AS has today extended TRS agreements relating to 2 385 808 shares in Solon Eiendom ASA. The new expiration of the TRS agreements are November 16, 2018 and the exercise price is NOK 26 [...]

Acarix Interim Report, January - June 2018 : Acarix gains traction in key markets providing physicians and patients new opportunities

21/08/2018 - 08:01

Interim Report, January - June 2018 Malmö, August 21, 2018 Acarix gains traction in key markets providing physicians and patients new opportunities "Since the inception of Acarix, the company has been fully committed to [...]

Navamedic ASA: Renews multiple key distribution agreements

21/08/2018 - 08:01

Oslo, August 21, 2018 - Navamedic ASA (OSE: NAVA) today announced it has renewed three partnership agreements with Vitaflo International Limited, Allerderm Laboratories and Qiagen GmbH for continued Nordic distribution [...]

Shire plc: Rule 2.9 Announcement

21/08/2018 - 08:00

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT JURISDICTION. 21 August 2018 [...]

Importance of Smallpox Vaccination Highlighted in Biopreparedness Exercise

21/08/2018 - 07:46

Conclusions from a tabletop exercise in Australia, simulating a smallpox outbreak in the Asia-Pacific, highlighted vaccination as a key preparedness parameter to prevent a pandemic and limit the outbreak consequences [...]

Santhera to Report First Half-Year Financial Figures and Provide Corporate Update on September 4, 2018

21/08/2018 - 07:01

Pratteln, Switzerland, August 21, 2018 - Santhera Pharmaceuticals (SIX: SANN) will announce its first half-year financial figures for 2018 and provide a corporate update on Tuesday, September 4, 2018, at 07:00 CEST / 06 [...]